The crystal structures of two proteins, a putative pyrazinamidase/nicotinamidase from the dental pathogen Streptococcus mutans (SmPncA) and the human caspase-6 (Casp6), were solved by de novo arsenic single-wavelength anomalous diffraction (As-SAD) phasing method. Arsenic (As), an uncommonly used element in SAD phasing, was covalently introduced into proteins by cacodylic acid, the buffering agent in the crystallization reservoirs. In SmPncA, the only cysteine was bound to dimethylarsinoyl, which is a pentavalent arsenic group (As (V)). This arsenic atom and a protein-bound zinc atom both generated anomalous signals. The predominant contribution, however, was from the As anomalous signals, which were sufficient to phase the SmPncA structure alone. In Casp6, four cysteines were found to bind cacodyl, a trivalent arsenic group (As (III)), in the presence of the reducing agent, dithiothreitol (DTT), and arsenic atoms were the only anomalous scatterers for SAD phasing. Analyses and discussion of these two As-SAD phasing examples and comparison of As with other traditional heavy atoms that generate anomalous signals, together with a few arsenic-based de novo phasing cases reported previously strongly suggest that As is an ideal anomalous scatterer for SAD phasing in protein crystallography.
References
[1]
Dauter Z, Dauter M, Dodson E (2002) Jolly SAD. Acta Crystallogr D Biol Crystallogr 58: 494–506.
[2]
Dauter Z (2005) Efficient use of synchrotron radiation for macromolecular diffraction data collection. Prog Biophys Mol Biol 89: 153–172.
[3]
Dodson E (2003) Is it jolly SAD? Acta Crystallogr D Biol Crystallogr 59: 1958–1965.
[4]
Dauter Z, Dauter M, de La Fortelle E, Bricogne G, Sheldrick GM (1999) Can anomalous signal of sulfur become a tool for solving protein crystal structures? J Mol Biol 289: 83–92.
[5]
Ramagopal UA, Dauter M, Dauter Z (2003) Phasing on anomalous signal of sulfurs: what is the limit? Acta Crystallogr D Biol Crystallogr 59: 1020–1027.
[6]
Dauter Z, Dauter M (2001) Entering a new phase: using solvent halide ions in protein structure determination. Structure 9: R21–26.
[7]
Dauter M, Dauter Z (2007) Phase determination using halide ions. Methods Mol Biol 364: 149–158.
[8]
Girard E, Chantalat L, Vicat J, Kahn R (2002) Gd-HPDO3A, a complex to obtain high-phasing-power heavy-atom derivatives for SAD and MAD experiments: results with tetragonal hen egg-white lysozyme. Acta Crystallogr D Biol Crystallogr 58: 1–9.
[9]
Girard E, Stelter M, Vicat J, Kahn R (2003) A new class of lanthanide complexes to obtain high-phasing-power heavy-atom derivatives for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 59: 1914–1922.
[10]
Hendrickson WA, Horton JR, LeMaster DM (1990) Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. EMBO J 9: 1665–1672.
[11]
Silvaggi NR, Martin LJ, Schwalbe H, Imperiali B, Allen KN (2007) Double-lanthanide-binding tags for macromolecular crystallographic structure determination. J Am Chem Soc 129: 7114–7120.
[12]
Peterson MR, Harrop SJ, McSweeney SM, Leonard GA, Thompson AW, et al. (1996) MAD Phasing Strategies Explored with a Brominated Oligonucleotide Crystal at 1.65A Resolution. J Synchrotron Radiat 3: 24–34.
[13]
Shepard W, Cruse WB, Fourme R, de la Fortelle E, Prange T (1998) A zipper-like duplex in DNA: the crystal structure of d(GCGAAAGCT) at 2.1 A resolution. Structure 6: 849–861.
[14]
Walden H (2010) Selenium incorporation using recombinant techniques. Acta Crystallogr D Biol Crystallogr 66: 352–357.
[15]
Retailleau P, Prange T (2003) Phasing power at the K absorption edge of organic arsenic. Acta Crystallogr D Biol Crystallogr 59: 887–896.
[16]
Brooks MA, Ravelli RB, McCarthy AA, Strub K, Cusack S (2009) Structure of SRP14 from the Schizosaccharomyces pombe signal recognition particle. Acta Crystallogr D Biol Crystallogr 65: 421–433.
[17]
Greenwald J, Le V, Butler SL, Bushman FD, Choe S (1999) The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. Biochemistry 38: 8892–8898.
[18]
Maignan S, Guilloteau JP, Zhou-Liu Q, Clement-Mella C, Mikol V (1998) Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J Mol Biol 282: 359–368.
[19]
Bentley R, Chasteen TG (2002) Microbial methylation of metalloids: arsenic, antimony, and bismuth. Microbiol Mol Biol Rev 66: 250–271.
[20]
Kenyon EM, Hughes MF (2001) A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. Toxicology 160: 227–236.
[21]
Tsao DH, Maki AH (1991) Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyl transferase. Biochemistry 30: 4565–4572.
[22]
Kabsch W (2010) Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr D Biol Crystallogr 66: 133–144.
[23]
Kabsch W (2010) Xds. Acta Crystallogr D Biol Crystallogr 66: 125–132.
[24]
Zwart PH, Grosse-Kunstleve RW, Adams PD (2005) Xtriage and Fest: automatic assessment of x-ray data and substurcuture structure factor estimation. CCP4 newsletter No.43.
[25]
Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr A 64: 112–122.
[26]
Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213–221.
[27]
Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
[28]
Delano WL (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, USA.
[29]
Leslie AGW (1992) Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF-EACMB Newsletter on Protein crystallography.
[30]
Evans P (2006) Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62: 72–82.
[31]
Collaborative Computational Project N (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760–763.
[32]
Wang XJ, Cao Q, Liu X, Wang KT, Mi W, et al. (2010) Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation. EMBO Rep 11: 841–847.
[33]
Hendrickson WA, Teeter MM (1981) structure of the hydrophobic protein crambin determined directly from the anomalous scattering of sulphur. Nature (london) 290: 107–113.
Terwilliger TC (2003) SOLVE and RESOLVE: automated structure solution and density modification. Methods Enzymol 374: 22–37.
[36]
Fyfe PK, Rao VA, Zemla A, Cameron S, Hunter WN (2009) Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide. Angew Chem Int Ed Engl 48: 9176–9179.
[37]
Chin KH, Tsai YD, Chan NL, Huang KF, Wang AH, et al. (2007) The crystal structure of XC1258 from Xanthomonas campestris: a putative procaryotic Nit protein with an arsenic adduct in the active site. Proteins 69: 665–671.
[38]
Dawson A, Gibellini F, Sienkiewicz N, Tulloch LB, Fyfe PK, et al. (2006) Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate. Mol Microbiol 61: 1457–1468.
[39]
Whitford D (2005) PEOTEINS: STRUCTURE AND FUNCTION. Amino acid: the building blocks of proteins. UK: John Wiley & Sons Ltd. pp. 19–21.
[40]
McCaldon P, Argos P (1988) Oligopeptide biases in protein sequences and their use in predicting protein coding regions in nucleotide sequences. Proteins 4: 99–122.
[41]
Wang BC (1985) Resolution of phase ambiguity in macromolecular crystallography. Methods Enzymol 115: 90–112.
[42]
Honbou K, Yuzawa S, Suzuki NN, Fujioka Y, Sumimoto H, et al. (2006) Crystallization and preliminary crystallographic analysis of p40phox, a regulatory subunit of NADPH oxidase. Acta Crystallogr Sect F Struct Biol Cryst Commun 62: 1018–1020.
[43]
Honbou K, Minakami R, Yuzawa S, Takeya R, Suzuki NN, et al. (2007) Full-length p40phox structure suggests a basis for regulation mechanism of its membrane binding. EMBO J 26: 1176–1186.
